Lake Street analyst Frank Takkinen initiates coverage on $Anteris Technologies Global (AVR.US)$ with a buy rating, and sets the target price at $20.
According to TipRanks data, the analyst has a success rate of 48.9% and a total average return of 8.4% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Anteris Technologies Global (AVR.US)$'s main analysts recently are as follows:
The timing for Anteris Technologies' entry into the transcatheter aortic valve replacement market appears optimal. The market clearly shows a persistent conflict between preferences for balloon-expandable valves and the requirements for superior hemodynamics in smaller valve sizes. Anteris' DurAVR could potentially cater to this demand by providing balloon-expandable valve delivery across all valve sizes, addressing the increasing needs for valve replacement.
Anteris Technologies has developed DurAVR, a first-in-class biomimetic transcatheter aortic valve replacement platform described as having 'disruptive potential.' The hemodynamic outcomes observed in its clinical development program set it apart and may enable Anteris to secure a significant market share in the $10B TAVR market if these results are replicated in subsequent trials.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
